<乌鸦传媒>Thiotepa-Based Conditioning Promising for Primary CNS Lymphoma Commonly used regimens with autologous transplant improved survival May 06, 2021
<乌鸦传媒>Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
<乌鸦传媒>Report: Worst Hospitals for Unnecessary Procedures Lown Institute says report is the first to name hospitals with high rates of overuse May 04, 2021
<乌鸦传媒>Op-Ed: Is FDA's Cigarette Ban Just Smoke and Menthols? Actually implementing a ban on menthol cigarettes and cigars could take years May 03, 2021
<乌鸦传媒>SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
<乌鸦传媒>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<乌鸦传媒>'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from 乌鸦传媒's sources May 02, 2021
<乌鸦传媒>New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
<乌鸦传媒>FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
<乌鸦传媒>Treatment Type a Non-Factor in Prostate Cancer Patients' Anxiety Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
<乌鸦传媒>Lung Cancer Survival Continues to Rise With Immunotherapy Twice as many patients with advanced NSCLC alive at 5 years with pembrolizumab vs chemo Apr 29, 2021
<乌鸦传媒>Vadadustat Matches Standard for CKD-Related Anemia, With Caveat Jury still out on drug's heart safety, which differed depending on dialysis dependence Apr 28, 2021
<乌鸦传媒>Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivors Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
<乌鸦传媒>What to Do With a Rare, Aggressive Bladder Cancer Case authors lament scant information on treatments or outcomes Apr 26, 2021
<乌鸦传媒>Why Clotting Happens When Platelets Are Low A hematologist explains the counterintuitive concept of clots with low platelets Apr 23, 2021
<乌鸦传媒>Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
<乌鸦传媒>Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
<乌鸦传媒>PD-1 Inhibitor Approved for dMMR Endometrial Cancer Dostarlimab led to 42.3% response rate in recurrent/advanced disease Apr 22, 2021
<乌鸦传媒>Late ADT a Problem in Prostate Cancer Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
<乌鸦传媒>Surveillance Spurned for Small Papillary Thyroid Tumors Nearly all head and neck surgeons would opt for lobectomy or total thyroidectomy Apr 22, 2021
<乌鸦传媒>Op-Ed: Dermatology Needs Lower Costs and Better Care A proposal for value-based care Apr 21, 2021
<乌鸦传媒>No More Men Need to Die From Transrectal Prostate Biopsies A movement toward transperineal biopsies Apr 21, 2021
<乌鸦传媒>Are Post-Mastectomy Lymphedema Precautions Needed for All? Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
<乌鸦传媒>Olympic Gold Medalist Nathan Adrian's Testicular Cancer The swimmer's diagnosis, treatment, and an "extra year" of pandemic prep for Toyko Apr 20, 2021
<乌鸦传媒>Poloxamer 188 Flops for Sickle Cell Disease Pain Study found no difference in duration of vaso-occlusive episodes versus placebo Apr 20, 2021
<乌鸦传媒>New Anti-PD1 Drugs Boost Survival in Treated Lung Cancer Questions about generalizability of results with China-developed therapies Apr 14, 2021
<乌鸦传媒>Another Player in Advanced Bladder Cancer Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy Apr 14, 2021
<乌鸦传媒>Targeted Drug Yields Durable Responses in Rare Blood Neoplasm Most advanced systemic mastocytosis patients responded to KIT D816V inhibitor Apr 13, 2021
<乌鸦传媒>Another FGFR Inhibitor Active in Bile Duct Cancers Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021
<乌鸦传媒>Dual Targeted Tx a 'Meaningful' Option in BRAF-Mutant Glioma One-third of glioblastoma patients responded to dabrafenib-trametinib Apr 12, 2021
<乌鸦传媒>More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
<乌鸦传媒>Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
<乌鸦传媒>A Win for Nivolumab as Preoperative Therapy for Lung Cancer Pathologic CR rate 12 times higher with the addition of anti-PD-1 agent to chemo Apr 11, 2021
<乌鸦传媒>Immunovirotherapy Shows Promise in Pediatric High-Grade Glioma Small study showed responses in 11 of 12 patients Apr 11, 2021
<乌鸦传媒>Nivolumab Alone Prevails in Resected Melanoma Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<乌鸦传媒>Mixed Results for Immunotherapy in Metastatic Prostate Cancer Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
<乌鸦传媒>Practice-Changing Results in Metastatic Uveal Melanoma Bispecific T cell-engaging tebentafusp reduces survival hazard by 50% Apr 10, 2021
<乌鸦传媒>Add-On PI3K Inhibitor Wins in Relapsed, Indolent NHL Adding copanlisib to rituximab also doubled CR rate, with manageable toxicity Apr 10, 2021
<乌鸦传媒>From VIPIT to VITT: Thrombosis and COVID Vaccines More data support link between adenovirus vector vaccines, blood clotting, and low platelets Apr 09, 2021
